Kite Lake Capital Management (UK) LLP Hedge Fund

Name: Kite Lake Capital Management (UK) LLP Q3 2019 13F Filing | 13F Explorer
Creator: Kite Lake Capital Management (UK) LLP
Published: 2020-03-10

Location: London, United Kingdom

CIK: 0001687444 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Mar 10, 2020

Total Value: $1.411B

Holdings (8)

SPY SPDR S&P 500 ETF TR 85.7%

Value $1.209B Shares 406,100 Est. Cost — Unrealized —

— WABCO HLDGS INC 5.6%

Value $78.77M Shares 588,899 Est. Cost $132.39 Unrealized —

— SPARK THERAPEUTICS INC 2.5%

Value $34.89M Shares 359,793 Est. Cost $102.30 Unrealized —

— VERSUM MATLS INC 1.9%

Value $26.84M Shares 506,989 Est. Cost $51.92 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 1.3%

Value $19.04M Shares 3,689,527 Est. Cost $7.09 Unrealized -21.2%

— PIVOTAL SOFTWARE INC 1.0%

Value $14.61M Shares 979,423 Est. Cost $14.92 Unrealized —

— GENESEE & WYO INC 1.0%

Value $14.19M Shares 128,384 Est. Cost $110.51 Unrealized —

— CHINA BIOLOGIC PRODS HLDGS I 1.0%

Value $13.8M Shares 120,573 Est. Cost $114.47 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SPY	SPDR S&P 500 ETF TR	406,100	$1.209B	85.7%	—	—	PUT	78462F103
—	WABCO HLDGS INC	588,899	$78.77M	5.6%	$132.39	—	—	92927K102
—	SPARK THERAPEUTICS INC	359,793	$34.89M	2.5%	$102.30	—	—	84652J103
—	VERSUM MATLS INC	506,989	$26.84M	1.9%	$51.92	—	—	92532W103
PACB	PACIFIC BIOSCIENCES CALIF IN	3,689,527	$19.04M	1.3%	$7.09	-21.2%	—	69404D108
—	PIVOTAL SOFTWARE INC	979,423	$14.61M	1.0%	$14.92	—	—	72582H107
—	GENESEE & WYO INC	128,384	$14.19M	1.0%	$110.51	—	—	371559105
—	CHINA BIOLOGIC PRODS HLDGS I	120,573	$13.8M	1.0%	$114.47	—	—	G21515104